Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study.

Merola, Joseph F; Chiou, Albert S; During, Emmanuel; Foley, Peter; Wu, Jiangming; Ardeleanu, Marius; Ozturk, Zafer E

Merola, Joseph F; Chiou, Albert S; During, Emmanuel; Foley, Peter; Wu, Jiangming; Ardeleanu, Marius; Ozturk, Zafer E.

Afiliação

Merola JF; Department of Dermatology, Medicine and Rheumatology, UT Southwestern Medical Center, Dallas, Texas. Electronic address: joseph.merola@gmail.com.
Chiou AS; Department of Dermatology, Stanford University, Palo Alto, California.
During E; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California; Division of Sleep Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California.
Foley P; Skin Health Institute, Carlton, Victoria, Australia; Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
Wu J; Sanofi, Bridgewater, New Jersey.
Ardeleanu M; Regeneron Pharmaceuticals Inc., Tarrytown, New York.
Ozturk ZE; Sanofi, Cambridge, Massachusetts.

J Am Acad Dermatol ; 2024 Jul 14.

Article em En | MEDLINE | ID: mdl-39009229